6 analysts have shared their evaluations of Alexandria Real Estate (NYSE:ARE) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 0 | 6 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 2 | 0 | 0 |
| 2M Ago | 0 | 0 | 3 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Analysts have recently evaluated Alexandria Real Estate and provided 12-month price targets. The average target is $56.0, accompanied by a high estimate of $63.00 and a low estimate of $47.00. This current average represents a 3.11% decrease from the previous average price target of $57.80.

In examining recent analyst actions, we gain insights into how financial experts perceive Alexandria Real Estate. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Carroll | RBC Capital | Maintains | Sector Perform | $60.00 | $60.00 |
| Ronald Kamdem | Morgan Stanley | Lowers | Equal-Weight | $54.00 | $55.00 |
| Peter Abramowitz | Jefferies | Raises | Hold | $57.00 | $47.00 |
| Anthony Paolone | JP Morgan | Lowers | Neutral | $63.00 | $65.00 |
| Ronald Kamdem | Morgan Stanley | Announces | Equal-Weight | $55.00 | - |
| Peter Abramowitz | Jefferies | Lowers | Hold | $47.00 | $62.00 |
Capture valuable insights into Alexandria Real Estate's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Alexandria Real Estate analyst ratings.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Negative Revenue Trend: Examining Alexandria Real Estate's financials over 3M reveals challenges. As of 31 December, 2025, the company experienced a decline of approximately -4.5% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Alexandria Real Estate's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -148.43%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Alexandria Real Estate's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -6.74%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -3.03%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Alexandria Real Estate's debt-to-equity ratio is below the industry average. With a ratio of 0.82, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.